Crime-scene compound targets malaria parasite

combat malariaIn the case of malarial research, ‘crime does pay.’ If everything goes according to the plan of researchers at Washington University School of Medicine in St. Louis, the compound used at crime scenes to find trace amounts of blood may one day be used to kill the malaria parasite.

The new study falls perfectly in sync with WHO guidelines which say that artemisinin — the most commonly used antimalarial drug — only be used in combination with other treatments because the parasite is becoming resistant to it.


The compound, luminol glows blue when it reacts with hemoglobin in red blood cells. The researchers have shown that they can use this glow to trick malaria-infected red blood cells into building up a volatile chemical stockpile.

To achieve this, the researchers first gave the infected red blood cells an unusual amino acid and then used the blue glow to trigger the chemical. The strategy worked in killing the parasite.

According to senior author Daniel Goldberg, professor of medicine and molecular microbiology, the blue light that luminol emits is enhanced by the antimalarial drug artemisinin. The results show that we can combine these two agents to form an effective treatment against the malarial parasite.

The results of the study are available online in the journal eLife.

The new approach targets proteins made by human red blood cells, which the parasite can’t mutate. In the study, researchers led by first author Paul Sigala, a scientist in Goldberg’s laboratory, analyzed human red blood cells infected with the malaria parasite. The first goal of the study was to understand how the parasite gets a hold of the deep red, non-protein part of hemoglobin (heme) that carries oxygen. Heme is essential to the parasite’s survival.

They discovered that the parasite opens an unnatural channel on the surface of red blood cells. When scientists put an amino acid used in the production of heme into the solution containing the cells, the amino acid entered the cells through the channel and started the heme-making process.


Further study showed that the amino-acid induced heme caused the buildup of a molecule called protoporphyrin IX. When this molecule is exposed to light it emits dangerous, chemically reactive compounds known as free radicals. These free radicals kill the parasite. The research team plans to test whether this approach can be replicated in animal studies.

Given that the amino acid, the luminol and artemisinin have been individually cleared for use in humans, the team is optimistic that safety will not be a problem when they are put together to kill the parasite. The team is extremely optimistic that this study could pave the way for a promising new treatment for a devastating disease. A disease which the WHO estimates infected 198-million people and killed 584,000 in 2013.


Author Bio

Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.


Popular Stories